DCB Open Innovation Challenge 2025: Meet our Top 15!
The DCB Open Innovation Challenge 2025 is proceeding to the next round! We are very happy to announce the Top 15 that have been selected by our evaluation committee.
Meet our Top 15!
After a thorough review of 54 remarkable submissions for our Open Innovation Challenge, our team has identified the 15 most promising ideas to move forward into the next stage.
We are excited to reveal the trailblazing concepts that have earned their place in this year’s cohort. From this talented group, 15 entrants will ultimately be chosen as finalists, securing a spot in our exclusive bootcamp and the chance to shine at our awards event.
We encourage you to discover the full profiles of our top 15 innovators in the attached PDF or down below!
Downloads
Alva Innovations Inc. (US) - In-line, just-in-time insulin fibril filtration — NO skin irritation!
Alva Innovations has developed a just-in-time filtration platform that removes insulin fibrils during pump therapy, thereby prolonging the lifespan of pump sets and maintaining healthy skin.
Diabetes Driving Pal (US) - Diabetes Driving Pal
The Diabetes Driving Pal app makes driving safer for people with diabetes with real-time voice alerts, trend analysis, and community support to prevent low blood sugar–related accidents.
Insuflo (IND) - An affordable insulin pump for people with diabetes
Insuflo is an affordable, discreet, smartphone-controlled insulin pump reducing upfront costs (~$1,200 vs. ~$7,200), combating diabetes stigma, and enabling open-source, community-driven innovation in resource-constrained settings.
Neuraura (CAN) - LoOoP by Neuraura: proactive management of diabetes risk in PCOS population (polycystic ovary syndrome)
LoOoP by Neuraura is a first in-kind solution for PCOS (polycystic ovary syndrome), combining a biowearable with a digital platform. 70% of individuals with PCOS develop insulin resistance and 50% develop pre-/diabetes before 40.
Noxisense (ARG) - Noxisense: Smart Device for Early and Objective Detection of Diabetic Neuropathy
A portable, AI-enhanced device that helps doctors detect diabetic nerve damage early—objectively, non-invasively, and before it leads to pain or amputations.
SynchNeuro (USA) - Brain signal-based non-invasive glucose monitor
SynchNeuro offers a discreet, brain-signal-based wearable and app for continuous glucose and cardiometabolic monitoring, targeting prediabetic and type 2 diabetes adults for $10/month.
U-Pump (USA) - Visage Pioneering the Visual Age
AI-powered wearable insulin patch pump with reusable cartridges, designed for affordability, comfort, and access in underserved diabetes populations.
YW MEMS (CHN) - Insulin patch pump drive
The MEMS MicroPump Module offers a highly integrated, precise, accurate and secure technology for insulin infusion, empowering the miniaturization and intelligent precision control for insulin pump.
Autocast (POL) - System AutoCast - a mission to transform diabetic wound healing
System AutoCast offers advanced wound therapy with smart monitoring at home, empowering patients in their recovery and giving doctors insights that improve care and prevent complications.
Diawiser (LTU) - Diawiser
Diawiser is a non-invasive software that detects blood glucose abnormalities with voice.
Kilele Health (US) - Multiparameter continuous monitoring to improve glucose prediction
Kilele will improve glucose prediction by making real-time hormone levels available to predictive algorithms. This breakthrough uses long-lived aptamer-chemistry biosensors configured similar to CGMs.
Niqs (UK) - QuEST - Quantum Enabled Sensing Technology
NIQS Tech’s GlucoGlass is a reusable, non-invasive glucose sensor offering accurate, eco-friendly diabetes monitoring, with 97% clinical accuracy and no single-use waste.
Preliqx (GER) - Nephronin®
Nephronin® is a highly sensitive and specific test for the early detection of kidney injury. It enables timely intervention and helping prevent kidney failure in patients with diabetes.
Syntactiq (AT) - Syno: Revolutionizing Diabetes Research
Syno revolutionizes diabetes research with a multi-agent AI platform and an unique contextualized dataset (1M+ patient-days), empowering rapid, insightful analysis for clinicians and researchers.
Visage Medical (ISR) - Visage Pioneering the Visual Age
Visage brings life-saving diabetes detection to millions without access to care, using AI and a simple selfie. It’s fast, non-invasive, and built to reach anyone, anywhere.
More recent news
DT-Report 2026: Join now
The survey for the DT Report 2026 is now available – Take part and help shape the future of diabetes technology with...
Alva Innovation wins the DCB Open Innovation Challenge 2025
Bern, 6 November 2025 - The start-up Alva Innovations has won first place in the DCB Open Innovation Challenge. The...
A Day of Innovation: Swiss Diabetes Technology and Beyond
Join us on 5 November 2025 at sitem-insel, Bern for a day dedicated to inspiring ideas and new perspectives in perspectives in medtech, diabetes technology and beyond.
DCB Research AG
Freiburgstrasse 3
3010 Bern
Switzerland